Effective July 31, 2026, Lallemand Inc. has completed its acquisition of BIO-CAT Enzymes & Microbials.
Together, we are combining complementary expertise in enzymes, microbial technologies, fermentation, and life science innovation to create an even stronger platform for developing next-generation solutions for the human health, animal nutrition, agriculture, food, and industrial markets.
BIO-CAT and Lallemand are expanding the possibilities for innovation while strengthening our commitment to delivering exceptional value to customers around the world.
